VERTEX PHARMACEUTICALS Stock Quote

$157.26 arrow  Change: 1.15 %Chge: 0.74% Vol: 90,695
End Of Day Prices
High: 157.29 | Low: 155.57 | Open: 155.64 | Close: 157.26
52 Wk High: 178.04 | 52 Wk Low: 115.17 | Todays Pivot: 156.71
Sector: Healthcare and Pharmaceuticals add stock to watch list

VRTX Chart


You need Flash Player to see the chart, please download from the link below

Get Adobe Flash player

Related Healthcare and Pharmaceuticals Companies

Steris 92.61 green arrow 6,422
Bio Rad Labs 124.57 red arrow 7,314
Medtronic 87.08 red arrow 436,072
Celgene 119.93 green arrow 197,611
Gilead Sciences 72.67 red arrow 372,480
Brookdale Sr Living 22.43 red arrow 114,092
Johnson & Johnson 136.5 red arrow 251,605
Humana 128.95 red arrow 49,385

Above is a small selection of related companies to Vertex Pharmaceuticals which compete alongside VRTX within the Healthcare and Pharmaceuticals sector. To see more related companies to VRTX, view our stock market today information page.

Online News For Vertex Pharmaceuticals

VRTX Crosses Above Key Moving Average Level

In trading on Friday, shares of Vertex Pharmaceuticals, Inc. (Symbol: VRTX) crossed above their 200 day moving average of $155.31, changing hands as high as $157.53 per share. Vertex Pharmaceuticals, Inc. shares are currently trading up about 3.8% on the day.


Vertex Pharmaceuticals Incorporated (VRTX) Rises 3.28% for May 11

Among the biggest risers on the S&P 500 on Friday May 11 was Vertex Pharmaceuticals Incorporated ($VRTX), popping some 3.28% to a price of $155.97 a share with some 2.23 million shares trading hands. Starting the day trading at $150.75, Vertex ...


Are Analysts Bullish Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) After Last Week?

Investors sentiment decreased to 1.34 in 2017 Q4. Its down 0.28, from 1.62 in 2017Q3. It turned negative, as 53 investors sold Vertex Pharmaceuticals Incorporated shares while 160 reduced holdings. 72 funds opened positions while 213 raised stakes.


Vertex Pharmaceuticals Inc (NASDAQ:VRTX) 2017 Q4 Sentiment Report

Vertex Pharmaceuticals Inc (NASDAQ:VRTX) institutional sentiment decreased to 1.34 in 2017 Q4. Its down -0.28, from 1.62 in 2017Q3. The ratio turned negative, as 285 investment professionals increased or started new equity positions, while 213 sold and ...


Biotech Stock Roundup: ALXN, VRTX Post Solid Results, GILD Disappoints in Q1

The Biotech space remained a key area of investors focus as several bigwigs announced quarterly results. While Alexion (ALXN - Free Report) reported solid results, Gilead (GILD - Free Report) reported dismal numbers. Among other developments over the week ...



Want To Add This Quote To Your Site?

With our stock widgets you can add a Vertex Pharmaceuticals quote to your website to keep your users up to date with the market. We have a variety of different styled widgets for VRTX to choose from. Visit here to build your stock quote widget »